Skip to content

Search for Biomarkers in Human Glaucoma: Lymphocytes Alterations and Rate of Progression

Search for Biomarkers in Human Glaucoma: Possible Correlations Between Alterations in Peripheral Lymphocytes and Disease Severity

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00981422
Enrollment
40
Registered
2009-09-22
Start date
2007-06-30
Completion date
2008-06-30
Last updated
2009-09-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glaucoma, Open-Angle

Keywords

glaucoma, immunology, immunophenotype

Brief summary

The aim of this study was to evaluate the lymphocyte phenotype in primary open- angle glaucoma (POAG) patients compared to healthy subjects of the same age, in order to confirm the importance of immune responses in glaucoma and the possible correlation to the severity of the disease.

Interventions

None listed

Sponsors

University of Parma
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
19 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* Clinical diagnosis of primary open-angle glaucoma * age between 19 an 85 years old

Exclusion criteria

* age less than 19 or more than 85 yrs * positive history for (a) neurodegenerative diseases, (b) autoimmune diseases, (c) cancer, (d) viral infection and (e) diabetes, (f)systemic inflammation

Design outcomes

Primary

MeasureTime frame
compare the lymphocyte phenotype of POAG patients to healthy subjects of the same agethe same day of bloodwithdrawal

Secondary

MeasureTime frame
correlate the immunophenotype of POAG patients to the severity of diseasewithin 3 months after blood withdrawal

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026